In summary, SALL1 functions as a putative tumor suppressor in GBM, but SALL2 and SALL4 are crucial for tumor development and progression, which is associated with PI3K/AKT pathway activation and the maintenance of an undifferentiated aggressive phenotype. This evidence concerns the gene SALL2 and glioblastoma.